• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

1999 Fiscal Year Final Research Report Summary

Development of optically active radioligand for biomedical imaging of neurotrasmission

Research Project

Project/Area Number 10470474
Research Category

Grant-in-Aid for Scientific Research (B)

Allocation TypeSingle-year Grants
Section一般
Research Field Physical pharmacy
Research InstitutionKYOTO UNIVERSITY

Principal Investigator

SAJI Hideo  Kyoto University, Graduate School of Pharmaceutical Sciences, Professor, 薬学研究科, 教授 (40115853)

Co-Investigator(Kenkyū-buntansha) OHMOMO Yoshiro  Osaka University of Pharmaceutical Sciences, Associate Professor, 助教授 (70183241)
MAGATA Yasuhiro  Kyoto University, Graduate School of Pharmaceutical Sciences, Associate Professor, 薬学研究科, 助教授 (20209399)
Project Period (FY) 1998 – 1999
KeywordsBrain / Nicotine receptor / Monoamine oxidase / Radioligand / Bioimaging / In vivo mapping / Benzodiazepine receptor / Optical isomer
Research Abstract

Dynamic biological imaging using nuclear medical imaging technique and the radioligand is effective for elucidation of the process of neurotransmission. In this study, the superior radiation properties of 123-I for nuclear medical imaging promoted us to synthesize a radioiodinated compound as a radioligand for imaging. In the molecular design, particular attention was given to optical isomerism since there are cases where a great difference for the affinity for receptors and enzymes is observed between optical isomers. To evaluate the activity of monoamine oxidase (MAO) in vivo, we synthesized a clorgyline analog iodinated at 6-position (6ICG) for MAO A and a Ro 16-6491 analogs iodinated 4-position (4Ro) for MAO B, respectively. Each compound showed a high affinity and selectivity for a corresponding enzyme. Furthermore, a good correlation was observed between the cerebral uptake of radioactivity after injection of radioligand and enzymatic activity. For the imaging of nicotinic cholinergic receptors, a radioiodinated nicotine analog iodinated at 5-position of the pyridine ring,5-iodo-A85380 (5IA) was synthesized and the obtained 5IA was evaluated as a potential radioligand for investigating brain nicotinic receptors. The results of binding affinity experiments revealed that the affinity of 5IA was 10-fold higher than that of (S)-nicotine. Regional cerebral distribution studies in mice and rats disclosed that the accumulation of 125-I-5IA was dense in the thalamus, intermediate in the cortex and less marked in the cerebellum. The marked regional cerebral distribution was reduced and uniformalized by the treatment with cytidine. Gathered data indicate that radioiodinated 6ICG, 4Ro, and 5IA are potential radioligands for in vivo imaging studies of cerebral neurotransmission.

  • Research Products

    (6 results)

All Other

All Publications (6 results)

  • [Publications] 佐治 英郎: "放射性診断薬の開発の現状と新しい動向"先端医療. 5(2). 45-49 (1998)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] H.Saji: "Targeted delivery of radiolabeled imaging and therapeutic agents: Bifunctional radiopharmaceutical."Critical Reviews in Therapeutic Drug Carrier Systems. 16(2). 209-244 (1999)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Y.Magata: "Effect of chronic (-)nicotine treament on rat cerebral benzodiazepine receptors."Nucl.Med.Biol... 27(1). 57-60 (2000)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] H. Saji: "Present state and furture of radio-pharamceuticals."Sentaniryou. 5 (2). 45-49 (1998)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] H. Saji: "Targeted delivery of radiolabeled imaging and therapeutic agents : Bifunctional radiopharamceutiacal."Critical Reviews in Therapeutic Drug Carrier Systems. 16 (2). 209-244 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Y.Magata, et al.: "Effect of chronic (-) nicotine treatment on rat cerebral benzodiazepine receptors."Nucl. Med. Biol. 27 (1). 57-60 (2000)

    • Description
      「研究成果報告書概要(欧文)」より

URL: 

Published: 2001-10-23  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi